To compensate for intrauterine growth restriction, the neonates usually are more insulin-sensitive and then undergo a period of accelerated postnatal growth [61], which is associated with increased risk of developing insulin resistance and eventually type 2 diabetes [62]. The gene discussed is INS; the disease is fetal growth restriction.